Status:
UNKNOWN
Peri-implantitis and Systemic Inflammation
Lead Sponsor:
Eastman Dental Insitute and Hospital
Conditions:
Peri-Implantitis and Systemic Inflammation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To investigate the effects of peri-implantitis (a disease around dental implants) and its treatment at both local and systemic levels using clinical and biological parameters. One study with two part...
Detailed Description
Dental implants provide the gold standard treatment modality for missing teeth in most clinical situations. However, patient-related, site-related and clinician-related factors play a significant part...
Eligibility Criteria
Inclusion
- At least 18 years of age and in good general health
- A minimum of 20 teeth
- Participants must have at least one implant in situ with peri-implantitis as per its case definition
- Must voluntarily agree to sign the consent form
Exclusion
- Currently on any weight reduction program
- History of diabetes
- Uncontrolled or currently undergoing treatment for systemic medical conditions
- Chronic treatment (defined as 2 weeks or more) of antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline assessment
- Taking statins drugs
- History of alcohol or drug abuse
- Self-reported pregnancy or breastfeeding
- Patients who have active periodontitis as per its case definition and/or have had treatment for periodontitis within the last 1 year
Key Trial Info
Start Date :
July 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT05964127
Start Date
July 19 2023
End Date
December 31 2025
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London
London, United Kingdom